Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Verrica Pharmaceuticals Inc. (VRCA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
1.9200-0.2500 (-11.52%)
At close: 04:00PM EDT
1.9100 -0.01 (-0.52%)
After hours: 06:30PM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
431
12,000
0
0
0
Operating Expense
38,809
42,908
40,181
30,080
21,878
Operating Income
-38,378
-30,908
-40,181
-30,080
-21,878
Net Non Operating Interest Income Expense
-4,236
-4,172
-2,512
1,877
1,231
Other Income Expense
-
-
-1
-4
-1
Pretax Income
-42,614
-35,080
-42,694
-28,207
-20,648
Net Income Common Stockholders
-42,614
-35,080
-42,694
-28,207
-20,648
Diluted NI Available to Com Stockholders
-42,614
-35,080
-42,694
-28,207
-20,648
Basic EPS
-
-1.30
-1.71
-1.13
-1.41
Diluted EPS
-
-1.30
-1.71
-1.13
-1.41
Basic Average Shares
-
27,044
24,996
24,898
14,663
Diluted Average Shares
-
27,044
24,996
24,898
14,663
Total Operating Income as Reported
-38,378
-30,908
-40,181
-30,080
-21,878
Total Expenses
38,809
42,908
40,181
30,080
21,878
Net Income from Continuing & Discontinued Operation
-42,614
-35,080
-42,694
-28,207
-20,648
Normalized Income
-42,614
-35,080
-42,694
-28,207
-20,648
Interest Income
113
123
521
1,877
1,231
Interest Expense
4,349
4,295
3,033
-
0
Net Interest Income
-4,236
-4,172
-2,512
1,877
1,231
EBIT
-38,265
-30,785
-39,661
-30,080
-20,648
EBITDA
-37,706
-
-
-
-
Reconciled Depreciation
559
472
229
257
20
Net Income from Continuing Operation Net Minority Interest
-42,614
-35,080
-42,694
-28,207
-20,648
Normalized EBITDA
-37,706
-30,313
-39,432
-29,823
-20,628
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement